JP2024510778A5 - - Google Patents
Info
- Publication number
- JP2024510778A5 JP2024510778A5 JP2023558324A JP2023558324A JP2024510778A5 JP 2024510778 A5 JP2024510778 A5 JP 2024510778A5 JP 2023558324 A JP2023558324 A JP 2023558324A JP 2023558324 A JP2023558324 A JP 2023558324A JP 2024510778 A5 JP2024510778 A5 JP 2024510778A5
- Authority
- JP
- Japan
- Prior art keywords
- independently selected
- alkyl
- pharmaceutically acceptable
- acceptable salt
- appears
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163166289P | 2021-03-26 | 2021-03-26 | |
| US63/166,289 | 2021-03-26 | ||
| PCT/IB2022/052720 WO2022201097A1 (en) | 2021-03-26 | 2022-03-24 | 1,3-substituted cyclobutyl derivatives and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024510778A JP2024510778A (ja) | 2024-03-11 |
| JP2024510778A5 true JP2024510778A5 (enExample) | 2025-04-01 |
Family
ID=80999265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023558324A Pending JP2024510778A (ja) | 2021-03-26 | 2022-03-24 | １，３－置換シクロブチル誘導体及びその使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11845730B2 (enExample) |
| EP (1) | EP4313951A1 (enExample) |
| JP (1) | JP2024510778A (enExample) |
| KR (1) | KR20230162660A (enExample) |
| CN (1) | CN117062804A (enExample) |
| AR (1) | AR125196A1 (enExample) |
| AU (1) | AU2022244467A1 (enExample) |
| CA (1) | CA3214066A1 (enExample) |
| IL (1) | IL307189A (enExample) |
| MX (1) | MX2023011377A (enExample) |
| PY (1) | PY2221203A (enExample) |
| TW (1) | TW202304864A (enExample) |
| UY (1) | UY39681A (enExample) |
| WO (1) | WO2022201097A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY39681A (es) * | 2021-03-26 | 2022-10-31 | Novartis Ag | Derivados de ciclobutilo 1,3–sustituidos y sus usos |
| JP2025531367A (ja) * | 2022-09-21 | 2025-09-19 | ボシュ ＋ ロム アイルランド リミテッド | Ｔｒｐｖ１アンタゴニストの結晶多形形態およびその製剤 |
| US20240148709A1 (en) * | 2022-11-08 | 2024-05-09 | Aisa Pharma, Inc. | Methods of treating eye pain and eye disorders |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6933311B2 (en) * | 2003-02-11 | 2005-08-23 | Abbott Laboratories | Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| JP2007524596A (ja) | 2003-02-28 | 2007-08-30 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | 共結晶医薬組成物 |
| EP1601665A2 (en) * | 2003-03-07 | 2005-12-07 | Glaxo Group Limited | Urea derivatives |
| GB0412769D0 (en) | 2004-06-08 | 2004-07-07 | Novartis Ag | Organic compounds |
| RU2451014C2 (ru) | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Новое производное гетероциклиден ацетамида |
| WO2008007780A1 (fr) * | 2006-07-13 | 2008-01-17 | Kyowa Hakko Kirin Co., Ltd. | Dérivé du pentadiènamide |
| NZ577980A (en) | 2006-12-27 | 2012-01-12 | Sanofi Aventis | Cycloalkylamine substituted isoquinolone derivatives |
| WO2012072512A1 (en) * | 2010-11-29 | 2012-06-07 | Glaxo Group Limited | N-cyclobutyl-imidazopyridine or -pyrazolopyridine carboxamides as trpv1 antagonists |
| DE102010052781A1 (de) | 2010-11-30 | 2012-05-31 | Trw Automotive Gmbh | Befestigungsvorrichtung und Befestigungsbaugruppe zur Befestigung eines Gasgenerators und Fahrzeuginsassenrückhaltesystem |
| EP2688866A1 (en) * | 2011-03-25 | 2014-01-29 | AbbVie Inc. | Trpv1 antagonists |
| US8754101B2 (en) * | 2011-04-11 | 2014-06-17 | Glaxo Group Limited | N-cyclobutyl-imidazopyridine-methylamine as TRPV1 antagonists |
| US9747862B2 (en) | 2015-11-02 | 2017-08-29 | Castar, Inc. | Method of immersive rendering for wide field of view |
| US10269906B2 (en) * | 2016-11-30 | 2019-04-23 | Taiwan Semiconductor Manufacturing Co., Ltd. | Semiconductor device having two spacers |
| WO2018151678A1 (en) * | 2017-02-15 | 2018-08-23 | Agency For Science, Technology And Research | Compounds for treatment of cancer and epigenetics |
| WO2018226976A1 (en) | 2017-06-08 | 2018-12-13 | Kura Oncology, Inc. | Methods and compositions for inhibiting the interaction of menin with mll proteins |
| IL283755B2 (en) | 2018-12-07 | 2026-04-01 | Univ Maryland | N-(Phenyl-4-methylamino)-5-naphthalene-1-sulfonamide compounds and pharmaceutical preparations containing them |
| UY39681A (es) * | 2021-03-26 | 2022-10-31 | Novartis Ag | Derivados de ciclobutilo 1,3–sustituidos y sus usos |
-
2022
- 2022-03-22 UY UY0001039681A patent/UY39681A/es unknown
- 2022-03-22 AR ARP220100676A patent/AR125196A1/es unknown
- 2022-03-23 PY PY202202221203A patent/PY2221203A/es unknown
- 2022-03-24 CN CN202280024266.2A patent/CN117062804A/zh active Pending
- 2022-03-24 KR KR1020237036535A patent/KR20230162660A/ko active Pending
- 2022-03-24 TW TW111111060A patent/TW202304864A/zh unknown
- 2022-03-24 EP EP22714016.7A patent/EP4313951A1/en active Pending
- 2022-03-24 JP JP2023558324A patent/JP2024510778A/ja active Pending
- 2022-03-24 US US17/656,313 patent/US11845730B2/en active Active
- 2022-03-24 AU AU2022244467A patent/AU2022244467A1/en active Pending
- 2022-03-24 CA CA3214066A patent/CA3214066A1/en active Pending
- 2022-03-24 MX MX2023011377A patent/MX2023011377A/es unknown
- 2022-03-24 IL IL307189A patent/IL307189A/en unknown
- 2022-03-24 WO PCT/IB2022/052720 patent/WO2022201097A1/en not_active Ceased
-
2023
- 2023-10-24 US US18/493,441 patent/US12435040B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024510778A5 (enExample) | ||
| CN107172879B (zh) | 抗白细胞介素-33抗体及其用途 | |
| JP2023021118A (ja) | 補体成分ｃ５抗体 | |
| JP2017514917A5 (enExample) | ||
| CN104829718A (zh) | 前列腺素e2结合蛋白及其用途 | |
| CA2227265A1 (en) | Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis | |
| JP2022507404A5 (enExample) | ||
| CN110662752B (zh) | 用于临床管理由衰老细胞引起或介导的病症以及治疗癌症的Bcl家族拮抗剂磷杂环化合物 | |
| WO2019151470A1 (ja) | 眼内血管新生及び／又は眼内血管透過性亢進を伴う眼科疾患の予防又は治療のための医薬 | |
| CN101484004A (zh) | 新型大麻素及使用方法 | |
| RU2424795C2 (ru) | Лечение аутоиммунных заболеваний | |
| JP2022520832A5 (enExample) | ||
| JP5955774B2 (ja) | プロスタグランジンアゴニストのプロドラッグの安定した水性組成物およびその使用方法 | |
| US10537563B2 (en) | Methods for treating ocular disease using inhibitors of CSF-1R | |
| CA3092815A1 (en) | Use of n-4-(hydroxycarbamoyl)benzyl derivatives in the treatment and prevention of dry eye | |
| WO2021145355A1 (ja) | 近視の治療、近視の予防および／または近視の進行抑制のための医薬組成物 | |
| RU2021126673A (ru) | Способы лечения боли на поверхности глаза | |
| JP2022152866A (ja) | コール酸またはコール酸誘導体を含有する老視の治療または予防剤 | |
| WO2021145356A1 (ja) | 近視の治療、近視の予防および／または近視の進行抑制のための医薬組成物 | |
| TW202131914A (zh) | 用於神經疾病或病狀的治療之新治療方案 | |
| KR101255578B1 (ko) | 뇌경색에 연관된 뇌혈관 장애를 치료하는데 유용한피라졸론 화합물 | |
| JP7429500B2 (ja) | 角膜上皮障害治療剤 | |
| JP2024171050A (ja) | 新規ニコチンアミド化合物及びその用途 | |
| JP2025014078A (ja) | 新規ニコチンアミド化合物及びその用途 | |
| RU2023127197A (ru) | Производные 1,3-замещенного циклобутила и способы их применения |